News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Jayant Vaidya: UK patients prefer receiving TARGIT-IORT while they are asleep during surgery
Photo of Jayant Vaidya taken from ucl.ac.uk
Sep 6, 2024, 10:50

Jayant Vaidya: UK patients prefer receiving TARGIT-IORT while they are asleep during surgery

Jayant Vaidya, 

“UK patients with breast cancer perceive even 5-day post-op radiotherapy as being greatly disruptive. They prefer receiving TARGIT-IORT while they are asleep during surgery – it gives them the feeling of stamping out the cancer without conscious awareness.”

Additional information

Source: Jayant Vaidya/X

cancer cancer awareness conscious awareness Jayant Vaidya OncoDaily Oncology TARGIT-IORT University College London
Special Coverage
Cancer Types
Apr 23, 2025, 13:57
Metastatic Lung Cancer: Causes, Symptoms, Treatment, and 2025 Advances in Therapy
Blog
Apr 23, 2025, 13:34
Kimryn Rathmell: I am thrilled to be joining to The Ohio State's James Cancer Hospital and Solove Research Institute as CEO
Blog
Apr 23, 2025, 13:23
Dr. Nita Radhakrishnan Wins Big at Precision Med India Awards 2025
Blog
Apr 23, 2025, 13:20
The Easter Discovery That Transformed Medicine: Marshall, Warren, and Helicobacter pylori
Blog
Apr 23, 2025, 13:17
Oliver Smithies: Scribbles That Changed the World of Genetics
Blog
Apr 23, 2025, 12:57
Darcy Burbage Honored with ONS’s 2025 Excellence in Social Media Impact Award
Blog
Apr 23, 2025, 11:43
Critical challenges in cell therapy development - Friends of Cancer Research
Blog
Apr 23, 2025, 11:31
When Circumstances Decide, Socioeconomic Status and Cancer Inequities in Europe - Youth Cancer Europe
Blog
Apr 23, 2025, 11:00
Olubukola Ayodele: The deep-rooted disparities ethnic minority groups face in breast cancer awareness, diagnosis in the UK
Science
Apr 23, 2025, 10:42
Federico Monaca: Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy
Insight
Apr 23, 2025, 10:35
Vignesh Packiam: I am generally aggressive in promoting bladder sparing for NMIBC
Blog
Apr 23, 2025, 10:33
Herbert Loong: It was a real pleasure meeting so many lung cancer friends